Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette-Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis

Veterinary Immunology and Immunopathology

Volumn 111, Issue 3-4, 2006, Pages 219-229

  Johnson, Linda ^a   Gough, Julie ^a   Spencer, Yvonne ^a   Hewinson, Glyn ^a   Vordermeier, Martin ^a   Wangoo, Arun ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Bovine; Granuloma; Immunohistochemistry; Lymph node; M. bovis; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

ACID FAST BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CATTLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DYNAMICS; FIBROSIS; GRANULOMA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LANGHANS GIANT CELL; LYMPH NODE; MACROPHAGE; MICROSCOPY; MYCOBACTERIUM BOVIS; NECROSIS; NONHUMAN; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD79; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BCG VACCINE; CATTLE; COLLAGEN TYPE I; GRANULOMA; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; MYCOBACTERIUM BOVIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS, BOVINE; TUBERCULOSIS, LYMPH NODE;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

EID: 33646139644     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.01.016     Document Type: Article

References (24)

1. Anderson P., and Doherty T.M. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3 (2005) 656-662
2. Aung H., Wu M., Johnson J.L., Hirsch C.S., and Toossi Z. Bioactivation of latent transforming growth factor beta1 by Mycobacterium tuberculosis in human mononuclear phagocytes. Scand. J. Immunol. 61 (2005) 558-565
3. 2 cytokine expression in human pulmonary tuberculosis. Tuberculosis 84 (2004) 375-385
4. Barnes P.F., Modlin R.L., and Ellner J.J. T-cell responses and cytokines. In: Bloom B.R. (Ed). Tuberculosis: Pathogenesis, Protection and Control (1994), American Society for Microbiology, Washington, DC 417-435
5. Bergeron A., Bonay M., Kambouchner M., Lecossier D., Riquet M., Soler P., Hance A., and Tazi A. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159 (1997) 3034-3043
6. Bloom B.R., and Fine P.E. The BCG experience. Implications for future vaccines against tuberculosis. In: Bloom B.R. (Ed). Tuberculosis: Pathogenesis, Protection and Control (1994), American Society for Microbiology, Washington, DC 531-537
7. Chackerian A.A., Perera T.V., and Behar S.M. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69 (2001) 2666-2674
8. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., and Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271 (1994) 698-702
9. DEFRA (Department for Environment, Food and Rural Affairs) document, 2004. Preparing for a new GB strategy on bovine tuberculosis, Crown copyright, UK.
10. Dieli F., Troye-Blomberg M., Ivanyi J., Fournie J.J., Bonneville M., Peyrat M.A., Sireci G., and Salerno A. Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 30 (2000) 1512-1519
11. Doherty T.M., Demissie A., Olobo J., Wolday D., Britton S., Eguale T., Ravn P., and Andersen P. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J. Clin. Microbiol. 40 (2002) 704-706
12. Fenhalls G., Stevens L., Bezuidenhout J., Amphlett G.E., Duncan K., Bardin P., and Lukey P.T. Distribution of IFN-γ, IL-4, and TNF-α protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas. Immunology 105 (2002) 325-335
13. Fine P.E. The BCG story: lessons from the past and implications for the future. Rev. Infect. Dis. 11 Suppl. 2 (1989) S353-S359
14. Flesch I.E., and Kaufmann S.H. Role of cytokines in tuberculosis. Immunobiology 189 (1993) 316-339
15. Hewinson R.G., Vordermeier H.M., and Buddle B.M. Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis 83 (2003) 119-130
16. Hoft D.F., Brown R.M., and Roodman S.T. Bacille Calmette-Guérin vaccination enhances human γδ T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J. Immunol. 161 (1998) 1045-1054
17. Langermans J.A., Andersen P., van Soolingen D., Vervenne R.A., Frost P.A., van der Laan T., van Pinxteren L.A., van den Hombergh J., Kroon S., Peekel I., Florquin S., and Thomas A.W. Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 11497-11502
18. Saunders B.M., and Cooper A.M. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 78 (2000) 334-341
19. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., Sette A., Brenner M.B., Porcelli S.A., Bloom B.R., and Modlin R.L. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276 (1997) 1684-1687
20. Toossi Z., and Ellner J. The role of TGF-β in the pathogenesis of human tuberculosis. Clin. Immunol. Immunopathol. 87 (1998) 107-114
21. Ulrichs T., Kosmiadi G.A., Trusov T., Jörg S., Pradl L., Titukhina M., Mishenko V., Gushina N., and Kaufmann S.H.E. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J. Pathol. 204 (2004) 217-228
22. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., and Hewinson R.J. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70 (2002) 3026-3032
23. Wangoo A., Johnson L., Gough J., Ackbar R., Inglut S., Hicks D., Spencer Y., Hewinson G., and Vordermeier M. Advanced granulomatous lesions in Mycobacteria bovis infected cattle are associated with increased expression of type I procollagen, γδ (WC1+) T cells and CD 68+ cells. J. Comp. Pathol. 133 (2005) 223-234
24. Worku S., and Hoft D.F. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect. Immun. 71 (2003) 1763-1773